Concepedia

A Food and Drug Administration–Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion

Claudio Bravo, Dorothy E. Vatner, Ronald Pachon, Jie Zhang, S. F. Vatner

Journal of Pharmacology and Experimental Therapeutics · 2016 · 22 citations · 29 references

DOIFull text

Open access

Concepts

References

29

Myocardial reperfusion: a double-edged sword?

Eugene Braunwald, Robert A. Kloner · Journal of Clinical Investigation · 1985 · 1.4K citations · Full text

, , +14

Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs.

Guy R. Heyndrickx, R. W. Millard, R. J. McRitchie et al. · Journal of Clinical Investigation · 1975 · 1K citations · Full text

, , +13

A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Adenosine as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction (AMISTAD-II)

Allan M. Ross, Raymond J. Gibbons, Gregg W. Stone et al. · Journal of the American College of Cardiology · 2005 · 596 citations

, , +13

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction

Kenneth W. Mahaffey, Joseph Puma, Alejandro Barbagelata et al. · Journal of the American College of Cardiology · 1999 · 542 citations

, , +14

Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A <sub>2B</sub> Adenosine Receptors

Tobias Eckle, Thomas Krahn, Almut Grenz et al. · Circulation · 2007 · 430 citations

, , +16